Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

By Wright G.L.   Grob M.   Haley C.   Grossman K.   Newhall K.   Petrylak D.   Troyer J.   Konchuba A.   Schellhammer P.F.   Moriarty R.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 326-334

Elsevier

Access to resources Recommend Favorite

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

By El-Galley R.E.S.   Petros J.A.   Sanders W.H.   Keane T.E.   Galloway N.T.M.   Cooner W.H.   Graham S.D.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 200-204

Elsevier

Access to resources Recommend Favorite

Reference range for prostate-specific antigen levels after external beam radiation therapy for adenocarcinoma of the prostate

By Geist R.W.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 1016-1021

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges

By Meshref A.W.   Bazinet M.   Trudel C.   Aronson S.   Peloquin F.   Nachabe M.   Dessureault J.   Aprikian A.G.   Begin L.R.   Elhilali M.M.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 972-979

Elsevier

Access to resources Recommend Favorite